English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

A genetic mouse model for progressive ablation and regeneration of insulin producing beta-cells.

MPS-Authors
/persons/resource/persons134431

Shamsi,  F.
Research Group of Molecular Cell Differentiation, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons15488

Mansouri,  A.
Research Group of Molecular Cell Differentiation, MPI for Biophysical Chemistry, Max Planck Society;

Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)

2111431_Suppl.tif
(Supplementary material), 6MB

Citation

Shamsi, F., Parlato, R., Collombat, P., & Mansouri, A. (2015). A genetic mouse model for progressive ablation and regeneration of insulin producing beta-cells. Cell Cycle, 13(24), 3948-3957. doi:10.4161/15384101.2014.952176.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0025-6BC0-D
Abstract
The putative induction of adult -cell regeneration represents a promising approach for the treatment of type 1 diabetes. Toward this ultimate goal, it is essential to develop an inducible model mimicking the long-lasting disease progression. In the current study, we have established a novel -cell ablation mouse model, in which the -cell mass progressively declines, as seen in type 1 diabetes. The model is based on the -cell specific genetic ablation of the transcription initiation factor 1A, TIF-IA, essential for RNA Polymerase I activity (TIF-IA(/)). Using this approach, we induced a slow apoptotic response that eventually leads to a protracted -cell death. In this model, we observed -cell regeneration that resulted in a complete recovery of the -cell mass and normoglycemia. In addition, we showed that adaptive proliferation of remaining -cells is the prominent mechanism acting to compensate for the massive -cell loss in young but also aged mice. Interestingly, at any age, we also detected -like cells expressing the glucagon hormone, suggesting a transition between - and -cell identities or vice versa. Taken together, the TIF-IA(/) mouse model can be used to investigate the potential therapeutic approaches for type 1 diabetes targeting -cell regeneration.